These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 3145357)
81. Predictive factors of histological response to primary chemotherapy in Ewing's sarcoma. Bacci G; Picci P; Mercuri M; Ferrari S; Longhi A; Cesari M; Rosito P; Mancini AF; Barbieri E; Baldini N Acta Oncol; 1998; 37(7-8):671-6. PubMed ID: 10050985 [TBL] [Abstract][Full Text] [Related]
82. Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: a Pediatric Oncology Group study. Pratt CB; Maurer HM; Gieser P; Salzberg A; Rao BN; Parham D; Thomas PR; Marcus RB; Cantor A; Pick T; Green D; Neff J; Jenkins JJ Med Pediatr Oncol; 1998 Apr; 30(4):201-9. PubMed ID: 9473754 [TBL] [Abstract][Full Text] [Related]
83. Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial. Le Deley MC; Paulussen M; Lewis I; Brennan B; Ranft A; Whelan J; Le Teuff G; Michon J; Ladenstein R; Marec-Bérard P; van den Berg H; Hjorth L; Wheatley K; Judson I; Juergens H; Craft A; Oberlin O; Dirksen U J Clin Oncol; 2014 Aug; 32(23):2440-8. PubMed ID: 24982464 [TBL] [Abstract][Full Text] [Related]
84. [Treatment of Ewing's sarcoma with intensive initial chemotherapy. 1st evaluation of a French pediatric multicenter protocol]. Deméocq F; Carton P; Patte C; Oberlin O; Sarrazin D; Lemerle J Presse Med; 1984 Mar; 13(12):717-21. PubMed ID: 6231575 [TBL] [Abstract][Full Text] [Related]
85. Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study. Granowetter L; Womer R; Devidas M; Krailo M; Wang C; Bernstein M; Marina N; Leavey P; Gebhardt M; Healey J; Shamberger RC; Goorin A; Miser J; Meyer J; Arndt CA; Sailer S; Marcus K; Perlman E; Dickman P; Grier HE J Clin Oncol; 2009 May; 27(15):2536-41. PubMed ID: 19349548 [TBL] [Abstract][Full Text] [Related]
86. Vincristine, doxorubicin, cyclophosfamide, actinomycin D, ifosfamide, and etoposide in adult and pediatric patients with nonmetastatic Ewing sarcoma. Final results of a monoinstitutional study. Ferrari S; Palmerini E; Alberghini M; Staals E; Mercuri M; Barbieri E; Longhi A; Cantero L; Cesari M; Abate M; Balladelli A; Picci P; Bacci G Tumori; 2010; 96(2):213-8. PubMed ID: 20572576 [TBL] [Abstract][Full Text] [Related]
87. [Therapy of non-metastatic Ewing's sarcoma (pelvis excluded). Results obtained in 48 cases combining local therapy (radiation and/or surgical) and adjuvant chemotherapy with vincristine, adriamycin, dactinomycin and cyclophosphamide]. Sudanese A; Avella M; Toni A; Boriani S; Baldini N; Monesi M; Battistini A; Mancini A; Campanacci M Minerva Med; 1987 Apr; 78(7):473-82. PubMed ID: 3574734 [TBL] [Abstract][Full Text] [Related]
88. Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy. Delepine N; Delepine G; Cornille H; Voisin MC; Brun B; Desbois JC J Chemother; 1997 Oct; 9(5):352-63. PubMed ID: 9373791 [TBL] [Abstract][Full Text] [Related]
89. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II. Burgert EO; Nesbit ME; Garnsey LA; Gehan EA; Herrmann J; Vietti TJ; Cangir A; Tefft M; Evans R; Thomas P J Clin Oncol; 1990 Sep; 8(9):1514-24. PubMed ID: 2099751 [TBL] [Abstract][Full Text] [Related]
90. Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age. Paioli A; Luksch R; Fagioli F; Tamburini A; Cesari M; Palmerini E; Abate ME; Marchesi E; Balladelli A; Pratelli L; Ferrari S J Chemother; 2014 Feb; 26(1):49-56. PubMed ID: 24091100 [TBL] [Abstract][Full Text] [Related]
91. [Neoadjuvant chemotherapy of sarcoma. The experiences of the German Society for Pediatric Oncology studies on osteosarcoma, Ewing's sarcoma and rhabdomyosarcoma]. Winkler K; Jürgens H; Treuner J Dtsch Med Wochenschr; 1987 Sep; 112(36):1385-90. PubMed ID: 3304927 [No Abstract] [Full Text] [Related]
92. Cyclophosphamide dose escalation in combination with vincristine and actinomycin-D (VAC) in gross residual sarcoma. A pilot study without hematopoietic growth factor support evaluating toxicity and response. Ruymann FB; Vietti T; Gehan E; Wiener E; Wharam M; Newton WA; Maurer H J Pediatr Hematol Oncol; 1995 Nov; 17(4):331-7. PubMed ID: 7583389 [TBL] [Abstract][Full Text] [Related]
93. Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma. United Kingdom Children's Cancer Study Group (UKCCSG). Shankar AG; Pinkerton CR; Atra A; Ashley S; Lewis I; Spooner D; Cannon S; Grimer R; Cotterill SJ; Craft AW Eur J Cancer; 1999 Nov; 35(12):1698-704. PubMed ID: 10674016 [TBL] [Abstract][Full Text] [Related]
94. Results of treatment for soft tissue sarcoma in childhood and adolescence: a final report of the German Cooperative Soft Tissue Sarcoma Study CWS-86. Koscielniak E; Harms D; Henze G; Jürgens H; Gadner H; Herbst M; Klingebiel T; Schmidt BF; Morgan M; Knietig R; Treuner J J Clin Oncol; 1999 Dec; 17(12):3706-19. PubMed ID: 10577842 [TBL] [Abstract][Full Text] [Related]
95. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. Bhatia S; Krailo MD; Chen Z; Burden L; Askin FB; Dickman PS; Grier HE; Link MP; Meyers PA; Perlman EJ; Rausen AR; Robison LL; Vietti TJ; Miser JS Blood; 2007 Jan; 109(1):46-51. PubMed ID: 16985182 [TBL] [Abstract][Full Text] [Related]
96. Extraosseous Ewing's sarcoma: report of a case and review of literature. Tay CH; Khiew KF; Kuo SH Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jan; 49(1):53-6. PubMed ID: 1372194 [TBL] [Abstract][Full Text] [Related]